Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Gaceta Medica De Mexico|May 31, 2001
[Laryngeal plasmacytoma]J L González-Rodríguez, E Cevallos-Barrera, A Aviles Miranda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
Meta-analysis to evaluate the role of interferon in follicular lymphomaA Z S Rohatiner, W M Gregory, B Peterson, et al.Applied Optics|December 18, 2023
Design and fabrication of a lightweight 3D first surface mirror aluminized by DC magnetron sputteringA M Bautista-Hernández, B Villalobos-Mendoza, R Izazaga-Pérez, et al.Cureus|July 8, 2024
Heart Failure With Improved Ejection Fraction: Prevalence, Predictors, and Guideline-Directed Medical TherapySheethal G Oommen, Ruzhual K Man, Keerthi Talluri, et al.BMC Cancer|December 25, 2008
Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studiesEva Barroso, Lara P Fernandez, Roger L Milne, et al.European Journal of Cancer (Oxford, England : 1990)|April 3, 2012
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysisMaider Ibarrola-Villava, Hui-Han Hu, Mickaël Guedj, et al.Molecular and Cellular Endocrinology|December 12, 2025
Prenatal perfluorooctanoic sulfonate exposure is associated with polycystic ovary syndrome-like and related traits in female offspring miceC Urrutia-Lopez, L González-Carranza, A Barajas-Salinas, et al.European Journal of Cancer (Oxford, England : 1990)|June 7, 2011
Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibilityMaider Ibarrola-Villava, Maria Peña-Chilet, Lara P Fernandez, et al.The Journal of Biological Chemistry|March 5, 2021
CowN sustains nitrogenase turnover in the presence of the inhibitor carbon monoxideMichael S Medina, Kevin O Bretzing, Richard A Aviles, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2006
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trialsJ Franklin, A Pluetschow, M Paus, et al.Pageof 5